Publication | Open Access

Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts

Hematological MalignancyMedicineImmune Checkpoint InhibitorsMalignant Blood DisorderImmunologyCell DeathImmune Checkpoint InhibitorAutoimmunityCell TransplantationImmunotherapyCytokine-induced Killer CellsCell BiologyNatural Killer CellsTumor MicroenvironmentMyeloid Neoplasia